ATLAS CAPITAL ADVISORS INC.

Position in BIIB — Biogen Inc.

CIK 1434165 JACKSON, WY

Position in BIIB

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$633,055

+$90,765 QoQ

Shares Held

2,930

-0.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#530

of 1,036 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ATLAS CAPITAL ADVISORS INC. holds $9,612,551 across 15 Drug Manufacturers - General names. BIIB ranks #4 (6.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,869	$4,640,595
2	GILD	Gilead Sciences, Inc.	7,901	$998,212
3	MRK	Merck & Co., Inc.	5,216	$670,256
4	BIIB	Biogen Inc. This page	2,930	$633,055
5	BMY	Bristol Myers Squibb Co	10,844	$624,831
6	AZN	Astrazeneca PLC	2,976	$564,309
7	AMGN	Amgen Inc	1,185	$429,112
8	GRFS	Grifols SA	31,637	$223,989

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$633,055	2,930	-0.9%	Shares	Sole	2026-08-13
2026-03-31	$542,290	2,958	+4.0%	Shares	Sole	2026-05-11
2025-12-31	$500,515	2,844	+4640.0%	Shares	Sole	2026-02-13
2023-09-30	$15,420	60	-31.8%	Shares	Sole	2023-11-14
2023-06-30	$25,066	88	0.0%	Shares	Sole	2023-08-15
2023-03-31	$24,466	88	-87.2%	Shares	Sole	2023-05-16
2022-12-31	$189,690	685	+379.0%	Shares	Sole	2023-02-15
2021-12-31	$34,308	143	-91.5%	Shares	Sole	2022-02-01
2021-09-30	$476,555	1,684	+189.3%	Shares	Sole	2021-10-28
2020-12-31	$142,508	582	-76.2%	Shares	Sole	2021-02-16
2020-09-30	$695,016	2,450	-51.8%	Shares	Sole	2020-10-23
2020-06-30	$1,361,026	5,087	+3813.1%	Shares	Sole	2020-07-28
2020-03-31	$41,129	130	—	Shares	Sole	2020-05-04
No filing history on record for this holder in this stock.